MedTrace Logo

Assessing Two Coenzyme Q10 Products in Men and Women

NCT07530250 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-05-19

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the relative bioavailability of coenzyme Q10 (CoQ10) from acute administrations of a CoQ10 product designed for enhanced absorption versus a standard CoQ10 product in healthy men and women. Participants will be asked to come to the clinical on five different occasions, including a screening visit (visit 1, -7 days), two test 1 visits (visits 2 and 3, days 0 and 1), and two test 2 visits (visits 4 and 5, days 7 and 8). During the start of each test visit (visits 2 and 4), the participant will consume each study product with water and a standardized breakfast meal. Then, blood samples will be collected over a 10-hour period, and a standardized lunch, dinner, and snacks will be provided. The participant will return to the clinic the next morning for a blood draw 24 hours after the study product ingestion from the previous day. The same procedures will be repeated 7 to 14 days later with the other study product.

Conditions

  • CoQ10 Blood Levels

Interventions

DIETARY_SUPPLEMENT

high absorption CoQ10 product

100 mg CoQ10 product designed for high absorption (administered as two 50 mg capsules)

DIETARY_SUPPLEMENT

standard CoQ10 product

100 mg standard CoQ10 product (administered as two 50 mg capsules)

Sponsors & Collaborators

  • Pharmavite LLC

    collaborator INDUSTRY

  • Midwest Center for Metabolic and Cardiovascular Research

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07530250 on ClinicalTrials.gov